Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kats

Showing results (771-780 of 801) with videos related to

Pageof 81
Sort By:
Journal of Clinical Gastroenterology|June 29, 2021
Per Oral Endoscopic Myotomy for Zenker's Diverticulum: A Novel and Superior Technique Compared With Septotomy?Michel Kahaleh, Noah Y Mahpour, Amy Tyberg, et al.
Immunity|April 16, 2021
Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell developmentLuyi Tian, Sara Tomei, Jaring Schreuder, et al.
Annals of Surgical Oncology|August 27, 2014
Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancerC Bisschop, J J J Tjalma, G A P Hospers, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 23, 2024
Giant Modulation of Refractive Index from Picoscale Atomic DisplacementsBoyang Zhao, Guodong Ren, Hongyan Mei, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Leukemia|April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphomaJonathan Wong, Emily Gruber, Belinda Maher, et al.
Nature Medicine|April 8, 2015
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancerShuo Wei, Shingo Kozono, Lev Kats, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Clinical Breast Cancer|November 25, 2023
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE RegistryKhava I E Ibragimova, Sandra M E Geurts, Dávid Laczkó, et al.
Nature Communications|March 7, 2017
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor geneMarcus Lefebure, Richard W Tothill, Elizabeth Kruse, et al.
Pageof 81

Showing results (771-780 of 801) with videos related to

Sort By:
Pageof 81
Journal of Clinical Gastroenterology|June 29, 2021
Per Oral Endoscopic Myotomy for Zenker's Diverticulum: A Novel and Superior Technique Compared With Septotomy?Michel Kahaleh, Noah Y Mahpour, Amy Tyberg, et al.
Immunity|April 16, 2021
Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell developmentLuyi Tian, Sara Tomei, Jaring Schreuder, et al.
Annals of Surgical Oncology|August 27, 2014
Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancerC Bisschop, J J J Tjalma, G A P Hospers, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 23, 2024
Giant Modulation of Refractive Index from Picoscale Atomic DisplacementsBoyang Zhao, Guodong Ren, Hongyan Mei, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Leukemia|April 23, 2022
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphomaJonathan Wong, Emily Gruber, Belinda Maher, et al.
Nature Medicine|April 8, 2015
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancerShuo Wei, Shingo Kozono, Lev Kats, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Clinical Breast Cancer|November 25, 2023
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE RegistryKhava I E Ibragimova, Sandra M E Geurts, Dávid Laczkó, et al.
Nature Communications|March 7, 2017
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor geneMarcus Lefebure, Richard W Tothill, Elizabeth Kruse, et al.
Pageof 81